Orogentx
1 known investors
Orogen Therapeutics is a drug discovery company that uses AI-enabled DNA-encoded library (DEL) technology and machine learning to identify novel small-molecule compounds targeting cytokine-related immuno-inflammatory disorders. The company focuses on developing oral small-molecule candidates for therapeutic areas including dermatology, rheumatology, and gastroenterology.
Founders & leadership
MP
Mark PykettCEO
Investors · 1
Frequently asked questions
- What does Orogentx do?
- Orogen Therapeutics is a drug discovery company that uses AI-enabled DNA-encoded library (DEL) technology and machine learning to identify novel small-molecule compounds targeting cytokine-related immuno-inflammatory disorders. The company focuses on developing oral small-molecule candidates for therapeutic areas including dermatology, rheumatology, and gastroenterology.
- Who are Orogentx's investors?
- Orogentx's investors include Novalis LifeSciences.